Brown Brothers Harriman & Co’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $777K | Sell |
4,088
-1,540
| -27% | -$265K | ﹤0.01% | 578 |
|
|
2026
Q1 | $950K | Hold |
5,628
| – | – | 0.01% | 438 |
|
|
2025
Q4 | $950K | Hold |
5,628
| – | – | 0.01% | 380 |
|
|
2025
Q3 | $813K | Sell |
5,628
-9
| -0.2% | -$1.23K | ﹤0.01% | 388 |
|
|
2025
Q2 | $713K | Sell |
5,637
-24
| -0.4% | -$2.95K | ﹤0.01% | 386 |
|
|
2025
Q1 | $724K | Sell |
5,661
-5,567
| -50% | -$755K | 0.01% | 341 |
|
|
2024
Q4 | $1.48M | Hold |
11,228
| – | – | 0.01% | 247 |
|
|
2024
Q3 | $1.63M | Buy |
11,228
+11,200
| +40,000% | +$1.62M | 0.01% | 237 |
|
|
2024
Q2 | $3.84K | Hold |
28
| – | – | ﹤0.01% | 1041 |
|
|
2024
Q1 | $3.84K | Buy |
+28
| New | +$3.82K | ﹤0.01% | 1056 |
|
|
2023
Q4 | – | Sell |
-95
| Closed | -$11.6K | – | 1208 |
|
|
2023
Q3 | $11.6K | Buy |
+95
| New | +$12.1K | ﹤0.01% | 917 |
|
|
2023
Q2 | – | Sell |
-142
| Closed | -$18.3K | – | 1261 |
|
|
2023
Q1 | $18.3K | Hold |
142
| – | – | ﹤0.01% | 910 |
|
|
2022
Q4 | $18.6K | Sell |
142
-3
| -2% | -$388 | ﹤0.01% | 906 |
|
|
2022
Q3 | $17K | Hold |
145
| – | – | ﹤0.01% | 1020 |
|
|
2022
Q2 | $17K | Sell |
145
-117
| -45% | -$13.9K | ﹤0.01% | 912 |
|
|
2022
Q1 | $34K | Hold |
262
| – | – | ﹤0.01% | 846 |
|
|
2021
Q4 | $40 | Hold |
262
| – | – | ﹤0.01% | 736 |
|
|
2021
Q3 | $42 | Sell |
262
-98
| -27% | -$16.5K | ﹤0.01% | 708 |
|
|
2021
Q2 | $59 | Hold |
360
| – | – | ﹤0.01% | 643 |
|
|
2021
Q1 | $54 | Hold |
360
| – | – | ﹤0.01% | 629 |
|
|
2020
Q4 | $55K | Sell |
360
-195
| -35% | -$27.9K | ﹤0.01% | 652 |
|
|
2020
Q3 | $75K | Sell |
555
-15
| -3% | -$2.04K | ﹤0.01% | 524 |
|
|
2020
Q2 | $78K | Sell |
570
-180
| -24% | -$22.9K | ﹤0.01% | 522 |
|
|
2020
Q1 | $81K | Sell |
750
-109
| -13% | -$12.5K | ﹤0.01% | 475 |
|
|
2019
Q4 | $104K | Hold |
859
| – | – | ﹤0.01% | 560 |
|
|
2019
Q3 | $85K | Buy |
859
+535
| +165% | +$56K | ﹤0.01% | 563 |
|
|
2019
Q2 | $35K | Buy |
+324
| New | +$34.5K | ﹤0.01% | 647 |
|
|
2018
Q1 | – | Sell |
-447
| Closed | -$48K | – | 951 |
|
|
2017
Q4 | $48K | Sell |
447
-450
| -50% | -$48.1K | ﹤0.01% | 516 |
|
|
2017
Q3 | $100K | Sell |
897
-228
| -20% | -$24.4K | ﹤0.01% | 405 |
|
|
2017
Q2 | $116K | Buy |
1,125
+375
| +50% | +$36.9K | ﹤0.01% | 393 |
|
|
2017
Q1 | $73K | Hold |
750
| – | – | ﹤0.01% | 449 |
|
|
2016
Q4 | $66K | Hold |
750
| – | – | ﹤0.01% | 450 |
|
|
2016
Q3 | $72K | Hold |
750
| – | – | ﹤0.01% | 408 |
|
|
2016
Q2 | $64K | Hold |
750
| – | – | ﹤0.01% | 425 |
|
|
2016
Q1 | $65K | Sell |
750
-186
| -20% | -$16.6K | ﹤0.01% | 414 |
|
|
2015
Q4 | $106K | Buy |
936
+186
| +25% | +$20.2K | ﹤0.01% | 385 |
|
|
2015
Q3 | $76K | Buy |
750
+450
| +150% | +$54K | ﹤0.01% | 443 |
|
|
2015
Q2 | $37K | Buy |
+300
| New | +$35.9K | ﹤0.01% | 529 |
|
|
2015
Q1 | – | Sell |
-450
| Closed | -$46K | – | 796 |
|
|
2014
Q4 | $46K | Hold |
450
| – | – | ﹤0.01% | 523 |
|
|
2014
Q3 | $41K | Sell |
450
-600
| -57% | -$52.7K | ﹤0.01% | 550 |
|
|
2014
Q2 | $90K | Hold |
1,050
| – | – | ﹤0.01% | 444 |
|
|
2014
Q1 | $83K | Hold |
1,050
| – | – | ﹤0.01% | 436 |
|
|
2013
Q4 | $79K | Hold |
1,050
| – | – | ﹤0.01% | 409 |
|
|
2013
Q3 | $73K | Hold |
1,050
| – | – | ﹤0.01% | 427 |
|
|
2013
Q2 | $61K | Buy |
+1,050
| New | +$60.7K | ﹤0.01% | 510 |
|
Other funds holding IBB
CB
Brown Brothers Harriman & Co's IBB Position: Q2 2026 in Review
Brown Brothers Harriman & Co reduced its iShares Biotechnology ETF (IBB) stake by 27% in Q2 2026, selling an estimated $265K and leaving 4,088 shares worth $777K. The position accounts for ﹤0.01% of the portfolio, ranked #578.
Brown Brothers Harriman & Co first reported a position in IBB in Q2 2013 and has held it in 45 quarters since. The position peaked at $1.63M in Q3 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Brown Brothers Harriman & Co held 4,088 shares of iShares Biotechnology ETF worth $777K as of Q2 2026.
- Brown Brothers Harriman & Co sold 1,540 iShares Biotechnology ETF shares in Q2 2026, an estimated $265K.
- iShares Biotechnology ETF made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #578 holding.
- Brown Brothers Harriman & Co first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 45 quarters since.
- Brown Brothers Harriman & Co's iShares Biotechnology ETF position peaked at $1.63M in Q3 2024.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.